1. Home
  2. QTRX vs STXS Comparison

QTRX vs STXS Comparison

Compare QTRX & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$2.61

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$2.01

Market Cap

190.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
STXS
Founded
2007
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.0M
190.6M
IPO Year
2017
2004

Fundamental Metrics

Financial Performance
Metric
QTRX
STXS
Price
$2.61
$2.01
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$6.00
$4.00
AVG Volume (30 Days)
1.4M
325.1K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
$37,632,000.00
$29,346,617.00
Revenue This Year
$25.49
$28.22
Revenue Next Year
$10.04
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
64.52
N/A
52 Week Low
$2.40
$1.70
52 Week High
$8.77
$3.59

Technical Indicators

Market Signals
Indicator
QTRX
STXS
Relative Strength Index (RSI) 35.48 58.32
Support Level $2.40 $1.97
Resistance Level $3.74 $2.12
Average True Range (ATR) 0.27 0.11
MACD 0.02 0.01
Stochastic Oscillator 23.76 82.43

Price Performance

Historical Comparison
QTRX
STXS

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: